Title: Depressive Disorders
Source: Castonguay CH. 2
Definition: Major Depressive Episode characterized by 5 or more symptoms, including:
Depressed mood (sad, down, blue)
Anhedonia (reduced interest/pleasure)
Appetite disturbance
Sleep disturbance
Feelings of worthlessness or inappropriate guilt
Loss of energy/fatigue
Difficulty concentrating or indecision
Psychomotor agitation or retardation
Recurrent thoughts of death or suicide
Duration: Symptoms must last for at least two weeks and occur for most of the day, not better explained by another medical condition or substance use.
Impact: Must cause clinically significant distress or impairment, distinct from normative responses to loss.
Beck Depression Inventory-2nd Edition
Item on loss of energy:
0: I have as much energy as ever.
1: I have less energy than I used to have.
2: I don’t have enough energy to do very much.
3: I don’t have enough energy to do anything.
Hamilton Rating Scale for Depression:
Item on changes in sleeping pattern:
0: No change in sleep pattern
1: Sleep somewhat more than usual
2: Sleep somewhat less than usual
...
Depressed Mood Scale:
0: Absent
1: Gloomy attitude, pessimism
2: Occasional weeping
3: Frequent weeping
4: Predominantly those feelings in communication.
Self-report method focusing on:
Changes in functioning
Onset and course
Severity of symptoms
Degree of functional impairment
Questioned: What are the etiology behind depressive symptoms?
Definition: Minimum duration of 2 years with:
Depressed mood and at least 2 additional symptoms of depression.
Symptoms must be present at least half of the time.
Note: Replaces ‘Dysthymia’ from DSM-IV, representing a more chronic form of MDD.
Major Depressive Disorder (MDD):
Lifetime prevalence is estimated at 12-16% in the U.S.
Point prevalence: ~8% at any given time.
Gender Ratio: Women to Men is approximately 2:1.
Persistent Depressive Disorder prevalence yet unknown (new category).
Former Dysthymic Disorder had a prevalence of about 2.5% lifetime.
Cohort effect: Increasing rates of depression in succeeding generations.
Approximately 60% of individuals with MDD also meet criteria for Anxiety Disorders.
Additionally often comorbid with:
Substance use disorders
Personality disorders
Speculated shared underlying mechanisms.
Heritability: Estimated at 37% for MDD; higher for severe cases.
Neurobiological factors:
Low levels of serotonin
Reduced sensitivity in serotonin receptors
Insensitive dopamine receptors.
Critique: "Chemical Imbalance" theory faces challenges due to insufficient evidence.
Deacon (2014): Mental disorders seen as brain diseases from neurotransmitter dysregulation, genetic factors, structural brain defects.
Lack of identified biological cause or reliable biomarkers for any mental disorder.
Claims about psychotropic medications correcting neurotransmitter imbalances lack credible evidence.
Key factors contributing to MDD include:
Life stressors
Interpersonal difficulties
Reduction in reinforcement
Negative cognitions:
Attentional biases: Tendency to focus on negative stimuli (sad, angry).
Dysfunctional thoughts: Rumination, negative attributional style attributing negative events internally, globally, and stably.
Early experiences may lead to dysfunctional assumptions affecting vulnerability to depression.
Critical incidents can trigger these assumptions, causing negative automatic thoughts which produce symptoms of depression, further fueling those thoughts.
Components involved:
Emotions
Cognitions
Behaviors
Neurobiological factors
Various medications include:
SSRIs (Selective Serotonin Reuptake Inhibitors)
SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
MAOIs (Monoamine Oxidase Inhibitors)
Irving Kirsch’s studies show effect sizes of antidepressants and placebos.
Antidepressants: High effect size (1.6)
Placebo: Effect size of 1.2
No-treatment controls: 0.37 (indicating natural improvement).
A significant portion of improvements attributed to expectancy effects and natural recovery.
Concerns expressed about selective publication bias affecting reported efficacy.
Summary of key findings regarding improvement in specific drug and placebo conditions across trials:
Fluoxetine: Drug: 8.30; Placebo: 7.34; Proportion: 0.89
Paroxetine: Drug: 9.88; Placebo: 6.67; Proportion: 0.68
Sertraline: Drug: 9.96; Placebo: 7.93; Proportion: 0.80
Others include Venlafaxine, Citalopram displaying similar trends.
Investigation of discrepancies between journal versions of antidepressant trials and FDA submissions.
Results show inconsistencies that influence perceived efficacy of treatments.
Other biological approaches include:
Electroconvulsive Therapy (ECT)
Transcranial Magnetic Stimulation (TMS)
Range of psychological therapies applied includes:
Interpersonal Therapy (IPT)
Cognitive Therapy (Cognitive-Behavioral Therapy)
Behavioral Therapy (Behavioral Activation)
Mindfulness-based approaches: Research indicates mindfulness training may outperform conventional methods for postpartum depression, though results can vary in real-world applications.
Aim: Identify and change depressive behaviors.
Techniques include:
Behavioral activation
Self-monitoring
Scheduling daily activities that bring pleasure or accomplishment.
Reducing avoidant behaviors.
Self-monitoring example:
Identify activities and associated emotional ratings (e.g. watching TV, lying in bed).
Understand behaviors worsening mood vs. opportunities for improvement.
Schedule alternative, goal-directed behaviors.
Engaging in alternative activities instead of less beneficial ones:
Replacing TV time with reading, walks, or chores.
Planned meals with friends over eating convenience foods.
Regulated TV before bed to improve sleep quality.
Cognitive approaches:
Objective: Modify distorted beliefs and thoughts.
Use thought records to capture and evaluate mood-related thoughts.
Benefits of combining CBT with medication noted.
Common cognitive distortions explained:
All-or-Nothing Thinking: Black or white thinking.
Fortune-Telling: Making negative predictions about the future.
Labeling: Assigning negative labels to oneself.
Emotional Reasoning: Believing feelings equate to reality.
Selective Abstraction: Focusing only on negative details.
Overgeneralization: Broad conclusions from limited evidence.
Mind Reading: Assuming to know others' thoughts.
Personalization and Blame: Taking events personally.
Should Statements: Strict standards for oneself.
Magnification/Minimization: Distorting the importance of events.
Format to analyze cognitive distortions by addressing the situation, thoughts, emotions, and outcomes:
Record date, time, situation.
Capture automatic thoughts and associated emotions.
Weigh evidence for/against thoughts.
Determine alternative responses.
Example analysis for "I’m a failure":
Evidence for: N/A
Evidence against: Lots of friends appreciate me, employed since college, honest.
Belief level: 20% for; 80% against.